Key result
Multimodality imaging plays a key role in refining the diagnosis, guiding therapy, and informing prognosis in patients with dilated cardiomyopathy.
Why the study?
Disease trajectory, treatment response, and outcomes vary widely in dilated cardiomyopathy, requiring refined diagnosis through multimodality imaging to guide therapy and inform prognosis.
Multimodality imaging plays a key role in refining the diagnosis, guiding therapy, and informing prognosis in patients with dilated cardiomyopathy.
Multimodality imaging may refine dilated cardiomyopathy diagnosis and therapy; leaves open prospective validation of prognostic benefit.
Dilated cardiomyopathy represents a common phenotype expressed in individuals with a family of overlapping myocardial diseases due to acquired and/or genetic susceptibility. Disease trajectory, response to therapy and outcomes vary widely; therefore, further refinement of the diagnosis can help guide therapy and inform prognosis. Multimodality imaging plays a key role in this process, as well as excluding alternative causes which may mimic a primary myocardial disease. The following article discusses the role of different imaging modalities as well as what the future may look like in the context of recent research innovations.
No takes yet. Share an insight, caveat, or question.
Brian P. Halliday (2022) conducted a review in Dilated cardiomyopathy. Multimodality imaging was evaluated. Multimodality imaging plays a key role in refining the diagnosis, guiding therapy, and informing prognosis in patients with dilated cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: